| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratoire de Biologie Hormonale (N.L., M.R.), Hôpital Saint-Vincent-de-Paul, 75014 Paris, France; Childrens Hospital of New York (I.F.), Division of Pediatric Endocrinology, Columbia University, New York, New York 10032; and Service dEndocrinologie Pédiatrique (J.-C.C.), Hôpital Saint-Vincent-de-Paul, 75014 Paris, France
Address all correspondence and requests for reprints to: Dr. Najiba Lahlou, Biologie Hormonale, Hôpital Saint-Vincent-de-Paul, 82 avenue Denfert-Rochereau, 75014 Paris, France. E-mail: najiba.lahlou{at}svp.ap-hop-paris.fr.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A renewed interest in testis function in Klinefelter subjects arose from the reports of successful pregnancies obtained in nonmosaic 47,XXY subjects by intracytoplasmic sperm injection after surgical sperm extraction or ejaculation (review in Ref. 6). There are still some controversies regarding the possibility of intratesticular mosaicism in subjects with the nonmosaic 47,XXY blood karyotype. However, these results request further assessment of testis functions from birth to adulthood, with the aim of bringing future assistance to parents in their decision to continue pregnancy, when the chromosomal abnormality was prenatally diagnosed.
The aim of this work was to investigate early in life the secretion of Sertoli and Leydig cell hormones. Owing to prenatal diagnosis of Klinefelter syndrome, we had the opportunity to compare hormonal data in a significant number of 47,XXY infants and to a large cohort of normal infants and to demonstrate that Sertoli cell function appears to be normal in infants with nonmosaic Klinefelter syndrome, in contrast to impaired Leydig cell secretion.
| Subjects and Methods |
|---|
|
|
|---|
Eighteen infants with homogenous 47,XXY karyotype were investigated for 13 yr (mean observation time, 610 d). The syndrome has been prenatally diagnosed by amniocentesis in the course of screening for Down syndrome or during the search of other chromosomal disorders. After comprehensive genetic counseling, including information on the high risk of infertility, parents chose to continue the pregnancy. They gave informed consent for a clinical and biological postnatal follow-up. The infants had normal height and weight at birth. Regular clinical and psychological consulting took place during the first 3 yr of life. Their growth rate and mental development for the period of observation was comparable with those of male infants with normal karyotype. Blood was collected at various intervals, one to three times during the first 3 yr of observation. A total of 50 individual samples were collected and distributed among five age groups, first month and 13, 48, 918, and 1936 months. Their biological data were compared with reference values established in our laboratory from 215 infants investigated for various reasons and found to be free of any endocrine or metabolic disorder. In addition, gonadotropins and testis hormones were measured in six adolescents with nonmosaic 47,XXY karyotype, aged 1418 yr.
Methods
Blood was collected in vacuum tubes, and the serum was immediately separated from cells and frozen. The specimens were shipped in dry ice and stored at 20 C until assayed.
FSH and LH were measured by a time-resolved fluorometric assay using Delfia reagents (Perkin Elmer Life Sciences, Courtaboeuf, France). Sensitivity for both assays was 0.01 IU/liter. Testosterone was measured by direct RIA using Orion reagents (CisBio International, Gif sur Yvette, France). Sensitivity was 0.01 ng/ml (0.05 nmol/liter). Inhibin B (INHB) was measured by an enzyme immunometric assay using Oxford Bio-Innovation reagents (Argene Biosoft, Varilhes, France), as described previously (7). Sensitivity was 6 pg/ml. Anti-Müllerian hormone (AMH) was measured by an enzyme immunometric assay using Immunotech reagents (Beckman Coulter, Villepinte, France). Sensitivity was 0.35 ng/ml (2.5 pmol/liter). SHBG was measured by means of Delfia reagents (Perkin Elmer Life Sciences). Sensitivity was 0.5 nmol/liter.
Statistics
The effects of age and clinical status (Klinefelter or control) were assessed by ANOVA using the Bonferroni/Dunn test. Correlations between hormone parameters were computed by means of the Spearmans rank test.
| Results |
|---|
|
|
|---|
|
|
INHB levels (Fig. 2
) increased significantly from birth to 4 months (P = 0.04) and then decreased progressively; they did not differ from controls. They were strongly correlated with FSH levels (r = 0.607, P = 0.0011) as in controls (r = 0.58, P = 0.0009). In an XXY boy who was given im testosterone enanthate (100 mg/m2) on d 40 and on d 55 of age, both FSH and INHB levels markedly declined and then increased as soon as normal FSH was restored (Fig 3
).
|
|
|
| Discussion |
|---|
|
|
|---|
Leydig cell secretion of testosterone is impaired early in infants with Klinefelter syndrome
The impairment of testosterone secretion is a well-known feature of Klinefelter syndrome in adult males (1). It is generally accompanied by a moderate increase of LH. A preliminary study by Sorensen et al. (8) showed that testosterone in cord blood from three neonates with 47,XXY karyotype was slightly lower than in three controls with normal karyotype. We report here that in infants bearing the 47,XXY karyotype, testosterone exhibited a physiological increase during the first trimester, but the mean level was lower than in normal infants. By contrast, LH levels were similar to those in normal infants, which might denote some degree of resistance to LH, related to the abnormal Leydig cell karyotype, because SHBG levels did not differ from controls. On the other hand, we found a significant correlation between testosterone and LH levels, similar to that previously reported by our group in normal infants (9). This observation raises the question of possible consequences of the blunted neonatal testosterone peak on the adult reproductive axis. Suppressing the neonatal testosterone peak in rhesus monkeys by administration of a LHRH agonist delays puberty; impairs testis development and secretion; induces oligozoospermia or azoospermia (10); suppresses the sexual activity when adult (11); and decreases the hypothalamic sensitivity to the neuromediator amino acid glutamate (12), which plays a key role in the onset of puberty (13). Nevertheless, pubertal development in adolescents with Klinefelter syndrome seems to occur at the appropriate time (14). In addition, it has also been shown in monkeys that treatment with a LHRH antagonist during the neonatal period lowers the social rank of adults (15). Although there have been no systematic evaluations of the social rank in Klinefelter subjects, it should be noticed that mental retardation has been repeatedly reported in recent literature.
In contrast to the impairment in Leydig cell secretion, INHB and AMH secretions are normal in 47,XXY infants.
Inhibin B levels are normal and clearly dependent on FSH
In normal male infants, high serum levels of INHB have been reported by several investigators (16, 17, 18). Similar data were obtained in our control group. Interestingly, male infants with nonmosaic 47,XXY karyotype have normal INHB secretion all along the observation period. Inhibin secretion is highly sensitive to FSH, as in normal males. There appears to be a similar strong correlation between INHB and FSH in XXY and control infants, and additionally in a boy, transiently treated with testosterone, INHB and FSH changes were also strictly parallel. This is consistent with the increase of INHB levels observed by Main et al. (19) in an infant treated with FSH for hypogonadotropic hypogonadism.
Conversely in 10 infants with normal karyotype treated with human chorionic gonadotropin (hCG) for 1 wk (1500 IU hCG im every other day), INHB levels fell from 200 ± 28 to 95 ± 17 pg/ml, whereas FSH levels decreased to levels close to the detection limit (our unpublished personal data).
This indicates that inhibin secretion by testis cells, bearing this sex chromosome polysomy, is not impaired in young prepubertal boys, in contrast to adolescents and adults. Whether inhibin secretion in XXY infants results exclusively from Sertoli cells remains to be determined. It should be noticed, however, that immunolocalization studies only in adult testes support the assumption of a significant contribution of germ cells to INHB production (16, 20).
AMH secretion, although not correlated with FSH, is dependent on the trophic effect of FSH on Sertoli cells
AMH secretion is normal in infants with 47,XXY karyotype. AMH levels increased progressively from the first month of life through 6 months of age as in normal infants (21). AMH levels are not correlated with FSH, and the reverse relationship with testosterone, reported by our group in adolescent males (22), was not found here in neither Klinefelter nor control infants. By contrast and despite the different temporal changes, we found a significant correlation between AMH and INHB levels, previously unreported. It has been shown that FSH increased the proportion of proliferating Sertoli cells in cultured rat testis fragments (23). In FSH-deficient transgenic mice, AMH levels and Sertoli cell number are decreased but restored by administration of recombinant FSH (24). Moreover, in primates several reports from Ramaswamy et al. (25) and Simorangkir et al. (26) have emphasized the effect of FSH on Sertoli cell proliferation. Therefore, is it likely that the correlation between AMH and INHB reflects the trophic effect of FSH on Sertoli cells, rather than direct dependency of AMH on FSH. Furthermore, AMH secretion remained high beyond the age of 1 yr, whereas FSH levels were strongly suppressed, suggesting that once initiated, AMH secretion by Sertoli cells does not require significant FSH stimulation. In addition, as shown in Fig 3
, the sharp decrease in FSH does not result in any decrease of AMH. Although anecdotic, this observation emphasizes the complexity of the mechanism regulating AMH secretion, which is still controversial. The reverse relationship with testosterone reported previously (22) is evident in boys treated for precocious puberty with a GnRH agonist: AMH levels significantly increased after testosterone suppression and are decreased after resumption of testis secretion (our personal unpublished data). On the other hand, short-term stimulation of testosterone secretion by hCG in prepubertal boys does not alter AMH (our unpublished data).
| Conclusion |
|---|
|
|
|---|
The role of germ cells in the regulation of Sertoli cell secretion is controversial. INHB secretion has been suggested to be up-regulated and AMH secretion to be down-regulated by germ cells (16, 29). The degeneration of germ cells after puberty could therefore impair INHB and AMH secretions. However, in nonmosaic Klinefelter syndrome, all Sertoli cells, when present in adult testis, have 47,XXY karyotype (30), and that could be enough to induce degeneration. On the other hand, in some subjects 47,XXY spermatogonia can undergo meiosis and give rise to X, Y, XX, and XY spermatozoa (30, 31). These findings have been challenged by other investigators who reported that only spermatogonia with a normal chromosomal pattern can produce mature sperm cells (32). However, both the successful intracytoplasmic sperm injection treatment of infertility in men with Klinefelter syndrome and the present evidence of normal Sertoli cell secretions in infants support the importance of elucidating the mechanism of secondary Sertoli and germ cell degeneration in adolescents with Klinefelter syndrome.
In addition, because there is experimental evidence in primates that testosterone secretion in the neonatal period can be important for adult sexual competence, the benefit of compensatory testosterone administration in Klinefelter infants during the first trimester of postnatal life deserves consideration.
| Acknowledgments |
|---|
| Footnotes |
|---|
This work was presented in part at the 41st Annual Meeting of the European Society for Paediatric Endocrinology, Madrid, Spain, September 2628, 2002.
Abbreviations: AMH, Anti-Müllerian hormone; hCG, human chorionic gonadotropin; INHB, inhibin B.
Received September 17, 2003.
Accepted December 23, 2003.
| References |
|---|
|
|
|---|
and ßB subunits and expression of corresponding messenger RNAs in the human adult testis. Biol Reprod 68:230235This article has been cited by other articles:
![]() |
S. E. Recabarren, T. Sir-Petermann, R. Rios, M. Maliqueo, B. Echiburu, R. Smith, P. Rojas-Garcia, M. Recabarren, and R. A. Rey Pituitary and Testicular Function in Sons of Women with Polycystic Ovary Syndrome from Infancy to Adulthood J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3318 - 3324. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bougneres, M. Francois, L. Pantalone, D. Rodrigue, C. Bouvattier, E. Demesteere, D. Roger, and N. Lahlou Effects of an Early Postnatal Treatment of Hypogonadotropic Hypogonadism with a Continuous Subcutaneous Infusion of Recombinant Follicle-Stimulating Hormone and Luteinizing Hormone J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2202 - 2205. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Aksglaede, N. E. Skakkebaek, and A. Juul Abnormal Sex Chromosome Constitution and Longitudinal Growth: Serum Levels of Insulin-Like Growth Factor (IGF)-I, IGF Binding Protein-3, Luteinizing Hormone, and Testosterone in 109 Males with 47,XXY, 47,XYY, or Sex-Determining Region of the Y Chromosome (SRY)-Positive 46,XX Karyotypes J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 169 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Aksglaede, J. H Petersen, K. M Main, N. E Skakkebaek, and A. Juul High normal testosterone levels in infants with non-mosaic Klinefelter's syndrome Eur. J. Endocrinol., September 1, 2007; 157(3): 345 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Coutant, D. Mallet, N. Lahlou, N. Bouhours-Nouet, A. Guichet, L. Coupris, A. Croue, and Y. Morel Heterozygous Mutation of Steroidogenic Factor-1 in 46,XY Subjects May Mimic Partial Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2868 - 2873. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mau Kai, K. M. Main, A. N. Andersen, A. Loft, N. E. Skakkebaek, and A. Juul Reduced Serum Testosterone Levels in Infant Boys Conceived by Intracytoplasmic Sperm Injection J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2598 - 2603. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M Main, J. Toppari, and N. E Skakkebaek Gonadal development and reproductive hormones in infant boys Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S51 - S57. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Soriano-Guillen, V. Mitchell, J.-C. Carel, P. Barbet, M. Roger, and N. Lahlou Activating Mutations in the Luteinizing Hormone Receptor Gene: A Human Model of Non-Follicle-Stimulating Hormone-Dependent Inhibin Production and Germ Cell Maturation J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3041 - 3047. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Eiholzer, D. l'Allemand, V. Rousson, M. Schlumpf, T. Gasser, J. Girard, A. Gruters, and M. Simoni Hypothalamic and Gonadal Components of Hypogonadism in Boys with Prader-Labhart- Willi Syndrome J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 892 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Suomi, K. M. Main, M. Kaleva, I. M. Schmidt, M. Chellakooty, H. E. Virtanen, K. A. Boisen, I. N. Damgaard, C. M. Kai, N. E. Skakkebaek, et al. Hormonal Changes in 3-Month-Old Cryptorchid Boys J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 953 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lefevre, C. Bouvattier, N. Lahlou, C. Adamsbaum, P. Bougneres, and J.-C. Carel Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor Eur. J. Endocrinol., February 1, 2006; 154(2): 221 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Aksglaede, A. M. Wikstrom, E. R.-D. Meyts, L. Dunkel, N. E. Skakkebaek, and A. Juul Natural history of seminiferous tubule degeneration in Klinefelter syndrome Hum. Reprod. Update, January 1, 2006; 12(1): 39 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Zinn, P. Ramos, F. F. Elder, K. Kowal, C. Samango-Sprouse, and J. L. Ross Androgen Receptor CAGn Repeat Length Influences Phenotype of 47,XXY (Klinefelter) Syndrome J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5041 - 5046. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lue, J. D. Jentsch, C. Wang, P. N. Rao, A. P. Sinha Hikim, W. Salameh, and R. S. Swerdloff XXY Mice Exhibit Gonadal and Behavioral Phenotypes Similar to Klinefelter Syndrome Endocrinology, September 1, 2005; 146(9): 4148 - 4154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Young, P. Chanson, S. Salenave, M. Noel, S. Brailly, M. O'Flaherty, G. Schaison, and R. Rey Testicular Anti-Mullerian Hormone Secretion Is Stimulated by Recombinant Human FSH in Patients with Congenital Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 724 - 728. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |